2008-08-25 13:05:00
Pittsburgh Business Times Names invivodata to 2008 Pittsburgh 100 PITTSBURGH, Aug. 25 // -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that the Pittsburgh Business Times has recognized the company in the "2008 Pittsburgh 100" annual ranking of the fastest-growing, privately-held companies in Western Pennsylvania. "We see the Pittsburgh 100 as one of the most important lists we publish," said Alan Robertson, publisher of the Pittsburgh Business Times. "The companies on this list represent many industries and many geographic locations around the region. The Pittsburgh 100 companies also represent all different sizes of companies, from small firms to multi-billion dollar operations. We see the Pittsburgh 100 as proof that the region remains a vibrant, growth-oriented business environment." Rankings on the list were based on the rate of growth from 2005 through 2007. Honored at an awards program at the Duquesne Club in downtown Pittsburgh on August 21, invivodata was ranked the 10th fastest-growing technology company and #43 overall on the list of 100, based on revenue growth. "We're very proud to be included in the Pittsburgh 100," said Doug Engfer, invivodata president and CEO. "We believe our inclusion in the list is representative of the consistent results we are delivering to our new and existing customers, and the growing demand for our ePRO solutions and expertise."
About invivodata inc. invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata's solutions include comprehensive trial-support services that facilitate the collection of ePRO data, and web-based access to study data and operational reports that give researchers and sponsors visibility into study progress and improve trial efficiencies. invivodata's solution has been used in more than 200 trials and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit http://www.invivodata.com/.
For more information, contact: invivodata inc. Christine Tobin Corporate Communications Specialist (412) 390-3000, ext. 3502 [email protected]
Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89
Get Unlimited Organic Website Traffic to your Website
TheNFG.com now offers Organic Lead Generation & Traffic Solutions